Bratton Capital Management, L.P.
Insider CIK 1723787 · AQST 10% owner · DNLI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 2,249,077 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 1,783,578 | — | $0 | 1,948,578 | SEC↗ |
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 40,404 | — | $0 | 47,051 | SEC↗ |
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 97,598 | — | $0 | 2,657,943 | SEC↗ |
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 524,675 | — | $0 | 1,688,639 | SEC↗ |
| AQST Aquestive Therapeutics, In | J Other | 2021-03-12 | 2021-03-16 | 564,160 | — | $0 | 3,468,747 | SEC↗ |
| AQST Aquestive Therapeutics, In | G Gift | 2021-03-09 | 2021-03-16 | 62,500 | — | $0 | 12,585 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2020-12-21 | 2020-12-23 | 383,411 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-12-14 | 2020-12-15 | 876 | $81.13 | $71.1K | 383,411 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-12-14 | 2020-12-15 | 16,949 | $80.35 | $1.36M | 384,287 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-12-11 | 2020-12-15 | 46,799 | $80.05 | $3.75M | 401,236 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-30 | 2020-06-30 | 200 | $24.34 | $4.9K | 448,035 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-30 | 2020-06-30 | 45,145 | $24.01 | $1.08M | 448,235 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-29 | 2020-06-30 | 61,807 | $23.84 | $1.47M | 514,151 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-29 | 2020-06-30 | 20,771 | $24.50 | $508.9K | 493,380 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-26 | 2020-06-30 | 13,604 | $24.67 | $335.6K | 575,958 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-26 | 2020-06-30 | 108,473 | $23.84 | $2.59M | 589,562 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-23 | 16,777 | $25.69 | $431.0K | 701,282 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-23 | 2020-06-23 | 3,247 | $26.19 | $85.0K | 698,035 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-22 | 2020-06-23 | 65,373 | $24.66 | $1.61M | 742,742 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-22 | 2020-06-23 | 24,683 | $25.12 | $620.0K | 718,059 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-19 | 2020-06-23 | 62,439 | $25.00 | $1.56M | 808,115 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-19 | 2020-06-23 | 82,481 | $24.20 | $2.00M | 870,554 | SEC↗ |
| DNLI Denali Therapeutics Inc. | J Other | 2019-03-25 | 2019-04-09 | 158,764 | — | $0 | 953,035 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-07-24 | 2018-07-26 | 165,000 | $15.00 | $2.48M | 165,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 128,200 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 240,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 2,500,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 1,875,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 743,599 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-14 | 14,499,999 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 2,500,000 | — | $0 | 17,312,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 14,499,999 | — | $0 | 14,812,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 1,875,000 | — | $0 | 19,187,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 743,599 | — | $0 | 743,599 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 128,200 | — | $0 | 871,799 | SEC↗ |
| DNLI Denali Therapeutics Inc. | P Buy | 2017-12-12 | 2017-12-14 | 275,000 | $18.00 | $4.95M | 19,462,499 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-14 | 240,000 | — | $0 | 1,111,799 | SEC↗ |